Douglas D Richman

发表

D. Richman, Douglas D Richman, 2006, Antiviral research.

Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection rather than Transmission and Evolution of Multiple Viral Variants

Jun Yong Choi, Sergei L. Kosakovsky Pond, Wayne Delport, 2011, Journal of Virology.

Minority variants of drug-resistant HIV.

D. Richman, S. Gianella, Douglas D Richman, 2010, The Journal of infectious diseases.

Update of the drug resistance mutations in HIV-1: Fall 2006.

Deenan Pillay, Victoria A Johnson, Francoise Brun-Vezinet, 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel

Amalio Telenti, Giuliano Rizzardini, Huldrych F Günthard, 2010 .

Update of the drug resistance mutations in HIV-1: Spring 2008.

Huldrych F Günthard, Deenan Pillay, Victoria A Johnson, 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages.

Jacques Corbeil, Christopher H Woelk, Roman Sasik, 2004, AIDS research and human retroviruses.

Editorial overview: Antivirals and resistance: Advances and challenges ahead

Luis Menéndez-Arias, Douglas D Richman, 2014, Current Opinion in Virology.

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Simon D W Frost, D. Richman, S. Little, 2003, The Journal of infectious diseases.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

Matthew C Strain, Diane V Havlir, D. Richman, 2005, The Journal of infectious diseases.

Update of the Drug Resistance Mutations in HIV-1: December 2008

Deenan Pillay, Victoria A Johnson, Francoise Brun-Vezinet, 2008 .

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Peter Reiss, Paul A Volberding, S. Hammer, 2008, JAMA.

Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel

Michael S Saag, Mauro Schechter, Paul A Volberding, 2006 .

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Victoria A Johnson, Daniel R Kuritzkes, Françoise Brun-Vézinet, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug resistance mutations in HIV-1.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2003, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B

Yang Liu, Terri Wrin, Colombe Chappey, 2005, Journal of Virology.

Update of the drug resistance mutations in HIV-1: Fall 2005.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Simon D W Frost, D. Richman, S. Little, 2007, The Journal of infectious diseases.

2015 Update of the Drug Resistance Mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2015, Topics in antiviral medicine.

The prevalence of antiretroviral drug resistance in the United States

Terri Wrin, Sally C Morton, Sandra Berry, 2004, AIDS.

HIV superinfection.

D. Richman, S. Little, Davey M. Smith, 2005, The Journal of infectious diseases.

Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.

Diederick E Grobbee, Michelle Moorhouse, D. Richman, 2017, The Lancet. Infectious diseases.

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

Mark Holodniy, Robert W Shafer, Daniel R Kuritzkes, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

Tao Dong, Nathalie Rufer, Susan Little, 2004, PLoS biology.

Antiretroviral-drug resistance among patients recently infected with HIV.

Elizabeth Connick, Richard A Koup, Lei Wang, 2002, The New England journal of medicine.

Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance

Susanne May, Christopher H Woelk, J. Margolick, 2008, AIDS.

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors: A Clinical Review of Antiretroviral Resistance

Joel E Gallant, R. Haubrich, D. Richman, 2002, Antiviral therapy.

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.

Jean-Michel Pawlotsky, Geoffrey Dusheiko, Fabien Zoulim, 2008, Gastroenterology.

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.

Yang Liu, Terri Wrin, Sergei L. Kosakovsky Pond, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Update of the drug resistance mutations in HIV-1: 2004.

Amalio Telenti, Deenan Pillay, Victoria A Johnson, 2004, Topics in HIV medicine : a publication of the International AIDS Society, USA.

2011 update of the drug resistance mutations in HIV-1.

Huldrych F Günthard, Vincent Calvez, Roger Paredes, 2011, Topics in antiviral medicine.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Michael S Saag, Mauro Schechter, Paul A Volberding, 2002, JAMA.

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Cheryl Jennings, Ian B Hogue, Sarah Palmer, 2005, The Lancet.

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

Michael S Saag, Mauro Schechter, Paul A Volberding, 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

A public health model for the molecular surveillance of HIV transmission in San Diego, California

Christopher H Woelk, Lydia Drumright, D. Richman, 2009, AIDS.